S. Korean quarantine authorities to discuss emergency approval on Remdesivir imports
Updated: 2020-05-28 14:21:27 KST
South Korea's quarantine authorities are set to review possible emergency approval on imports of (rem-dessy-veer) Remdesivir, an Ebola treatment that has emerged as a new hope in tackling COVID-19.
A group of infectious disease experts held related discussions on Thursday.
A senior official from the Korea Centers for Disease Control and Prevention said during a press briefing this week that depending on the outcomes of the experts' meeting, necessary procedures will be dealt with by the Ministry of Food and Drug Safety.
According to the U.S. National Institutes of Health, Remdesivir has successfully shortened the median recovery time from fifteen days to eleven.